Trastuzumab
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Status | complete |
|---|---|
| Category (CPV) | 33600000 |
| Region | Wales |
| Deadline | 1 Mar 2021 |
| Procedure | open |
| OCID | ocds-h6vhtk-028d8d |
Awards (7)
This procurement was awarded to 7 suppliers. Values shown are per-award; the notice total is ·.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | · | · | active |
| Alcura UK Ltd shared | · | · | active |
| Healthcare at Home shared | · | · | active |
| Napp Pharmaceutical Group Ltd shared | · | · | active |
| Organon Pharma (UK) Limited shared | · | · | active |
| Pfizer Limited shared | · | · | active |
| Roche Products Ltd shared | · | · | active |
description
Trastuzumab
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 26 Jan 2021 | Contract notice (F02) | Earlier regulations | 001591-2021 |
| 26 Jul 2021 | Contract award notice (F03) | Earlier regulations | 017730-2021 |
more from Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts
- Transitional Drugs 3 · £15,169,777 · 14 May 2025
- Ustekinumb · £6,069,376 · 4 Apr 2025
- Home Parenteral Nutrition Services · 25 Oct 2024
- Transitional Drugs 2 · £11,310,772 · 15 Dec 2023
- Hepatitis C Medicines · 9 Jun 2023
- All Wales Low and Mid Tech Medicines Homecare Services · 28 Apr 2022
- Biosimilars and Biologics · 26 Jul 2021
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.